Min Li, PhD
Deputy Editor for Cancer Letters Journal
Min Li, PhD will present in person. Attendees may participate in person or virtually by registering at the following link.
Register in advance for this webinar here
Min Li, PhD is the George Lynn Cross Research Professor of Medicine, Surgery, and Cell Biology at The University of Oklahoma Health Sciences Center (OUHSC), and holds the Virginia Kerley Cade Endowed Chair in Cancer Treatment. He is the Assistant Dean for International Research Collaboration at the College of Medicine, and Associate Director for Global Oncology at the NCI-designated Stephenson Cancer Center (SCC). He is also the Director of GI Cancer Research at the Department of Medicine, the Vice-Chair for Research at the Department of Surgery, and Co-Leader of the Cancer Biology Program of SCC at OUHSC. He is a leading expert on pancreatic cancer (PC), and his research mainly focuses on studying PC pathogenesis and developing new therapies. Dr. Li’s group is the first to identify a key zinc transporter ZIP4, which is aberrantly expressed in PC and promotes cancer growth, drug resistance, muscle wasting, cachexia, and metastasis. He has published more than 200 papers on high impact journals such as PNAS, EMBO Mol Med, Nature, Nature Communications, Gastroenterology, Can Res, Clin Can Res, JAMA Network Open, EBioMedicine (by Lancet), etc., and has four active NIH/NCI R01 grants, and multiple private foundation grants.